Dutaglandin® comp. contains the active substances dutasteride and tamsulosin.
Dutasteride belongs to the group of 5-alpha-reductase inhibitors and tamsulosin to the group of alpha-blockers.
Dutasteride lowers the production of the hormone dihydrotestosterone and thus helps to reduce the size of the prostate and relieve symptoms. It significantly reduces the risk of acute urinary retention and surgical intervention.
Tamsulosin relaxes the muscles of the prostate gland, thereby facilitating the flow of urine and leading to a rapid improvement in symptoms.
Dutaglandin® comp. is used to treat men with enlarged prostates (benign prostatic hyperplasia) if they are already being treated with tamsulosin and dutasteride at the same time. Benign prostatic hyperplasia is a non-cancerous growth of the prostate gland caused by an increased production of a hormone called dihydrotestosterone.
| Strength | Pack size |
| 0,5 mg/0,4 mg | 30 |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information